Contact
Please use this form to send email to PR contact of this press release:
Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with Sitagliptin
TO:
Please use this form to send email to PR contact of this press release:
Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with Sitagliptin
TO: